AbbVie Inc. Long-term Debt and Lease Obligation
AbbVie Inc. (ABBV) had Long-term Debt and Lease Obligation of $62.48 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2026-08-03
- 2026-06-30: Long-term Debt and Lease Obligation $62.48B.
- 2026-03-31: Long-term Debt and Lease Obligation $64.53B.
- 2025-12-31: Long-term Debt and Lease Obligation $58.94B.
- 2025-09-30: Long-term Debt and Lease Obligation $62.97B.
| Period end | Long-term Debt and Lease Obligation | Long-term Debt and Lease Obligation as first filed |
|---|---|---|
| 2026-06-30 | $62.48B 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $64.53B 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $58.94B 10-Q · filed 2026-08-03 | |
| 2025-09-30 | $62.97B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $62.96B 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $64.53B 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $60.34B 10-K · filed 2026-02-20 | |
| 2024-09-30 | $58.51B 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $58.05B 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $63.80B 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $52.19B 10-K · filed 2025-02-14 | |
| 2023-09-30 | $55.63B 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $55.81B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $59.29B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $59.13B 10-K · filed 2024-02-20 | |
| 2022-09-30 | $60.40B 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $61.00B 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $63.52B 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $64.19B 10-K · filed 2023-02-17 | |
| 2021-09-30 | $74.05B 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $74.24B 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $74.18B 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $77.55B 10-K · filed 2022-02-18 | |
| 2020-09-30 | $82.28B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $82.06B 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $63.28B 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $62.98B 10-K · filed 2021-02-19 | |
| 2019-09-30 | $33.13B 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $31.62B 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $35.07B 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $35.00B 10-K · filed 2020-02-21 | |
| 2018-09-30 | $36.49B 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $30.58B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $30.91B 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $30.95B 10-K · filed 2019-02-27 | |
| 2017-09-30 | $33.97B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $33.82B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $36.53B 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $36.44B 10-K · filed 2018-02-16 | |
| 2016-09-30 | $37.28B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $37.33B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $29.49B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $29.24B 10-K · filed 2017-02-17 | |
| 2015-09-30 | $31.36B 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $27.12B 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $10.68B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $10.54B 10-K · filed 2016-02-19 | $10.56B 10-K · filed 2015-02-20 |
| 2014-09-30 | $14.47B 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $14.47B 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $14.39B 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $14.29B 10-K · filed 2015-02-20 | |
| 2013-09-30 | $14.38B 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $14.33B 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $14.60B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $14.63B 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |